Early cerebral small vessel disease and brain volume, cognition, and gait

Annals of Neurology

Volumn 77, Issue 2, 2015, Pages 251-261

  Smith, Eric E ^a,b   O'Donnell, Martin ^c   Dagenais, Gilles ^d   Lear, Scott A ^e   Wielgosz, Andreas ^f   Sharma, Mukul ^c   Poirier, Paul ^d   Stotts, Grant ^f   Black, Sandra E ^g   Strother, Stephen ^h   Noseworthy, Michael D ⁱ   Benavente, Oscar ^j   Modi, Jayesh ^b   Goyal, Mayank ^a,b   Batool, Saima ^b   Sanchez, Karla ^b   Hill, Vanessa ^b   McCreary, Cheryl R ^b   Frayne, Richard ^a,b   Islam, Shofiqul ^c   DeJesus, Jane ^c   Rangarajan, Sumathy ^c   Teo, Koon ^c   Yusuf, Salim ^c   more..

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e SIMON FRASER UNIVERSITY   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h ROTMAN RESEARCH INSTITUTE   (Canada)

ⁱ MCMASTER UNIVERSITY   (Canada)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN CORTEX; BRAIN INFARCTION; BRAIN REGION; BRAIN SIZE; CANADIAN; CEREBELLUM; CEREBROVASCULAR DISEASE; COGNITION; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DIGIT SYMBOL SUBSTITUTION TEST; FEMALE; GAIT; GRAY MATTER; HUMAN; LEFT HEMISPHERE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONTREAL COGNITIVE ASSESSMENT; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PARIETAL CORTEX; PREFRONTAL CORTEX; PREVALENCE; PRIORITY JOURNAL; TASK PERFORMANCE; TEMPORAL CORTEX; TIMED UP AND GO TEST; WHITE MATTER; ATROPHY; BRAIN; CANADA; CEREBRAL SMALL VESSEL DISEASES; EARLY DIAGNOSIS; EPIDEMIOLOGY; HEALTH SURVEY; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; PSYCHOLOGY;

ADULT; AGED; ATROPHY; BRAIN; CANADA; CEREBRAL SMALL VESSEL DISEASES; COGNITION; EARLY DIAGNOSIS; FEMALE; GAIT; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES;

EID: 84922740193     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24320     Document Type: Article

References (30)

1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689-701.
2. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007;6:611-619.
3. LADIS Study Group. 2001-2011: a decade of the LADIS (Leukoaraiosis And DISability) Study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis 2011;32:577-588.
4. Debette S, Beiser A, DeCarli C, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 2010;41:600-606.
5. Vermeer SE, Den Heijer T, Koudstaal PJ, et al. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2003;34:392-396.
6. Singh-Manoux A, Kivimaki M, Glymour MM, et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ 2012;344:d7622.
7. Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011;378:1231-1243.
8. Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006;37:2220-2241.
9. Kaplan E, Fein D, Morris R, Delis D. The WAIS-R as a neuropsychological instrument. San Antonio, TX: Psychological Corporation, 1991.
10. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-699.
11. Bohannon RW. Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants. Age Ageing 1997;26:15-19.
12. Gunter JL, Bernstein MA, Borowski BJ, et al. Measurement of MRI scanner performance with the ADNI phantom. Med Phys 2009;36:2193-2205.
13. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822-838.
14. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341-355.
15. Desikan RS, Segonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006;31:968-980.
16. Hoyer WJ, Stawski RS, Wasylyshyn C, Verhaeghen P. Adult age and digit symbol substitution performance: a meta-analysis. Psychol Aging 2004;19:211-214.
17. Kenny RA, Coen RF, Frewen J, et al. Normative values of cognitive and physical function in older adults: findings from the Irish Longitudinal Study on Ageing. J Am Geriatr Soc 2013;61(suppl 2):S279-S290.
18. Pendlebury ST, Cuthbertson FC, Welch SJ, et al. Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke 2010;41:1290-1293.
19. Rosano C, Newman AB, Katz R, et al. Association between lower digit symbol substitution test score and slower gait and greater risk of mortality and of developing incident disability in well-functioning older adults. J Am Geriatr Soc 2008;56:1618-1625.
20. Bohannon RW. Reference values for the timed up and go test: a descriptive meta-analysis. J Geriatr Phys Ther 2006;29:64-68.
21. Kohara K, Fujisawa M, Ando F, et al. MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: the NILS-LSA Study. Stroke 2003;34:1130-1135.
22. DeCarli C, Massaro J, Harvey D, et al. Measures of brain morphology and infarction in the Framingham heart study: establishing what is normal. Neurobiol Aging 2005;26:491-510.
23. Schmidt R, Ropele S, Enzinger C, et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian Stroke Prevention study. Ann Neurol 2005;58:610-616.
24. Ikram MA, Vernooij MW, Vrooman HA, et al. Brain tissue volumes and small vessel disease in relation to the risk of mortality. Neurobiol Aging 2009;30:450-456.
25. Hoogendam YY, van der Geest JN, van der Lijn F, et al. Determinants of cerebellar and cerebral volume in the general elderly population. Neurobiol Aging 2012;33:2774-2781.
26. van Velsen EF, Vernooij MW, Vrooman HA, et al. Brain cortical thickness in the general elderly population: the Rotterdam Scan Study. Neurosci Lett 2013;550:189-194.
27. Maillard P, Seshadri S, Beiser A, et al. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol 2012;11: 1039-1047.
28. Mortamet B, Bernstein MA, Jack CR Jr, et al. Automatic quality assessment in structural brain magnetic resonance imaging. Magn Reson Med 2009;62:365-372.
29. Han X, Jovicich J, Salat D, et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade andmanufacturer. Neuroimage 2006;32:180-194.
30. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002;15:870-878.